WS

Wolfgang Sadee

OF Ohio State Innovation Foundation: 5 patents #54 of 979Top 6%
University of California: 4 patents #2,189 of 18,278Top 15%
OU Ohio State University: 1 patents #193 of 531Top 40%
📍 Upper Arlington, OH: #8 of 127 inventorsTop 7%
🗺 Ohio: #4,899 of 73,341 inventorsTop 7%
Overall (All Time): #313,871 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDate
12161641 Treatments and prevention of opioid neonatal abstinence syndrome John Oberdick 2024-12-10
10991450 Materials and methods for determining metabolizer status in humans Danxin Wang 2021-04-27
10925870 Treatments and prevention of opioid neonatal abstinence syndrome John Oberdick 2021-02-23
9938576 Materials and methods for determining metabolizer status in humans Danxin Wang 2018-04-10
9441275 Polymorphism in CYP3A4 gene affecting drug metabolizing and uses thereof Danxin Wang 2016-09-13
9061024 Combination analgesic employing opioid agonist and neutral antagonist Edward Bilsky, Janet Yancey-Wrona 2015-06-23
9012143 Polymorphisms in genes affecting ace-related disorders and uses thereof Andrew David Johnson, Danxin Wang, Audrey C. Papp 2015-04-21
8883817 Combination analgesic employing opioid and neutral antagonist Edward Bilsky, Janet Yancey-Wrona 2014-11-11
8748448 Combination analgesic employing opioid agonist and neutral antagonist Edward Bilsky, Janet Yancey-Wrona 2014-06-10
6953779 Melanocortin receptor antagonists and modulations of melanocortin receptor activity Edward T. Wei, J. Mark Quillan, Guennady P. Vlasov, Jaw-Kang Chang 2005-10-11
6713488 Neutral antagonists and use thereof in treating drug abuse Danxin Wang 2004-03-30
6270979 Methods for anti-addictive narcotic analgesic treatments 2001-08-07
6228840 Melanocortin receptor antagonists and modulations of melanocortin receptor activity Edward T. Wei, J. Mark Quillan, Guennady P. Vlasov 2001-05-08
6007986 Methods for anti-addictive narcotic analgesic activity screening 1999-12-28
5882944 Methods for G protein coupled receptor activity screening 1999-03-16